Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.85 USD
+0.02 (2.60%)
Updated Apr 29, 2024 02:06 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.35 | 1.92% |
Earnings Summary
For their last quarter, Viracta Therapeutics (VIRX) reported earnings of -$0.35 per share, missing the Zacks Consensus Estimate of -$0.30 per share. This reflects a negative earnings surprise of 16.67%. Look out for VIRX's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year decrease of 9.38%.
Earnings History
Price & Consensus
Zacks News for VIRX
Does Sunesis (VIRX) Have the Potential to Rally 335% as Wall Street Analysts Expect?
VIRX: What are Zacks experts saying now?
Zacks Private Portfolio Services